Table 4 Sputum and peripheral blood cellular profiles at baseline
From: Tolerance and rebound with zafirlukast in patients with persistent asthma
β2-agonist alone | ICS-treated | Significance | |
|---|---|---|---|
*TCC × 10 3 /ml | 41.5 (11.1–235.3) | 30.0 (0.5–293.8) | NS |
Sputum eosinophils, % | 4.6 (0.8–20.4) | 6.0 (0.2–39.2) | NS |
Cys-LT pg/ml | 266.4 (1.0–1343.6) | 297.6 (60.3–763.1) | NS |
PGE 2 pg/ml | 966 (371.6–1950.5) | 1358,5 (149.1–6155.3) | NS |
PB eosinophils, × 10 9 | 4.3 (1.1–12.7) | 3.3 (1.2–9.8) | NS |
PB neutrophils, × 10 9 | 3.2 (2.0–6.2) | 3.65 (1.1–6.2) | NS |
eNO (ppb) | 31 (9–77) | 15 (8–32) | p < 0.001 |